Ari Maizel, Chief Commercial Officer: Axsome Therapeutics AXSM Sell · Filed 01/23

Trade details

Type: Insider sale
Amount: $1,383,300
Shares · price: 7,500 sh · $184.44 a share
Held after: 0 sh
Stock: Axsome Therapeutics AXSM
Person: Ari MaizelChief Commercial Officer
Trade date: 26/01/21
Filed: 26/01/23
Days to filing: 2 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/22~02/20

Ari Maizel's recent trades

Ari MaizelChief Commercial Officer
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
7,500 sh
$1.4M
Filed 04/23
Traded 04/22
Ari MaizelChief Commercial Officer
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
7,500 sh
$1.4M
Filed 04/22
Traded 04/22
Ari MaizelChief Commercial Officer
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
7,500 sh
$1.4M
Filed 01/21
Traded 01/21